FourThought Financial Partners LLC Makes New $325,000 Investment in Acadia Healthcare Company, Inc. $ACHC

FourThought Financial Partners LLC purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 22,911 shares of the company’s stock, valued at approximately $325,000.

Several other institutional investors have also modified their holdings of ACHC. EverSource Wealth Advisors LLC grew its stake in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Bayforest Capital Ltd acquired a new position in shares of Acadia Healthcare during the fourth quarter worth $52,000. Hantz Financial Services Inc. grew its stake in shares of Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares in the last quarter. Finally, Covestor Ltd grew its stake in shares of Acadia Healthcare by 36.0% during the third quarter. Covestor Ltd now owns 6,004 shares of the company’s stock worth $149,000 after purchasing an additional 1,589 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on ACHC shares. Jefferies Financial Group reiterated a “hold” rating and set a $24.50 target price on shares of Acadia Healthcare in a research note on Monday, April 20th. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. Guggenheim boosted their target price on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Leerink Partners boosted their target price on shares of Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a research note on Thursday, February 26th. Finally, Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Acadia Healthcare has a consensus rating of “Hold” and an average target price of $26.04.

Acadia Healthcare Price Performance

Shares of ACHC opened at $23.18 on Friday. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $30.20. The stock has a market cap of $2.13 billion, a PE ratio of -1.89, a price-to-earnings-growth ratio of 7.74 and a beta of 0.73. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm has a fifty day moving average price of $25.21 and a 200 day moving average price of $19.32.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same period in the previous year, the company earned $0.40 earnings per share. Acadia Healthcare’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.49 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.